Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT07380139
PHASE1

Dexamethasone vs Dexmedetomidine in Sphenopalatine Ganglion Block for Rhinoplasty Pain

Sponsor: Ain Shams University

View on ClinicalTrials.gov

Summary

This study will test the effect of adding dexamethasone versus dexmedetomidine as adjuvants to bupivacaine in sphenopalatine ganglion block used for pain after rhinoplasty

Official title: Dexamethasone Versus Dexmedetomidine as Adjuvant to Bupivacaine in Sphenopalatine Ganglion Block as Post-operative Analgesia in Rhinoplasty Surgeries

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

90

Start Date

2026-02-01

Completion Date

2027-01-01

Last Updated

2026-02-02

Healthy Volunteers

Yes

Interventions

DRUG

Dexamedomedine

will receive bupivacaine 0.25% (3ml) + dexmedetomidine (1 mic/kg), total volume 5ml by adding normal saline.

DRUG

Dexamethasone

will receive bupivacaine 0.25% (3ml) + dexamethasone (4mg), total volume 5ml by adding normal saline

DRUG

Bubpivacaine

will receive bupivacaine 0.25% (3ml) + normal saline, total volume (5 ml).

Locations (1)

Ain Shams University

Cairo, Egypt